H&N Evaluation and management of esophageal cancer Flashcards

1
Q

What are the risk factors for cervical esophageal

squamous cell carcinoma?

A

● Tobacco
● Alcohol
● Gastroesophageal reflux
● Plummer-Vinson syndrome

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
2
Q

What is the most common type of cervical

esophageal cancer?

A

Squamous cell carcinoma (approximately 80%)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
3
Q

What is the most common type of distal esophageal cancer?

A

Adenocarcinoma. Increasing incidence related to gastroesophageal reflux disease

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
4
Q

What are common initial symptoms in patients

with cervical esophageal cancer?

A

Progressive dysphagia (solids, then solids and liquids) and
weight loss. Other symptoms include hematemesis, pain,
hoarseness or cough.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
5
Q

What are the typical nasopharyngoscopy findings

in patients with cervical esophageal cancer?

A

Negative findings unless esophagoscopy is performed or

tumor extends to the hypopharynx.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
6
Q

According to the AJCC, 7th edition, the cervical
esophagus begins at approximately what distance
from the incisors?

A

15 cm to less than 20 cm

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
7
Q

What imaging modality is most accurate at
identifying the extent of cervical esophageal cancer
and its relationship with adjacent soft tissues?

A

MRI

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
8
Q

What procedure is generally required for direct
visualization, biopsy, and staging of an esophageal
tumor?

A

EGD

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
9
Q

What procedure or diagnostic test is the most
sensitive for T and N staging for esophageal
cancer?

A

EUS

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
10
Q

What is the new T staging system for cervical
esophageal squamous cell carcinoma according to
the AJCC 7th edition?

A

T1a invades lamina propria or muscularis mucosa
T1b invades submucosa
T2 invades muscularis propria
T3 invades adventitia
T4a resectable tumor; invades pleura, pericardium, or diaphragm
T4b invades adjacent structures such as aorta or vertebral body and considered unresectable

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
11
Q

What is the N staging system for cervical
esophageal squamous cell carcinoma according to
the AJCC 7th edition?

A

N0 no regional metastasis
N1 1–2 regional lymph nodes
N2 3–6 regional lymph nodes
N3 ≥ 7 lymph node metastasis

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
12
Q

Describe the staging system used to classify

esophageal cancer based on the TNM stage.

A
● Stage IA: T1N0
● Stage IA: T2N0
● Stage IIA: T3N0
● Stage IIB: T1-T2N1
● Stage IIIA: T4aN0, T3N1, T1–2N2
● Stage IIIB: T3N2
● Stage IIIC: T4aN1–2, T4bAnyN, AnyTN3
● Stage IV: M1
How well did you know this?
1
Not at all
2
3
4
5
Perfectly
13
Q

What tumor characteristics have been recently
added to the AJCC, 7th edition, staging of
esophageal cancer?

A

● Histologic type (squamous cell carcinoma versus adenocarcinoma)
● Histologic grade (1–3)
● Tumor location (upper, middle, or lower esophagus)

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
14
Q

Although cervical esophageal and hypopharyngeal
squamous cell carcinomas are commonly grouped
together, what is an important difference in
staging at presentation?

A

Hypopharyngeal squamous cell carcinoma has a higher
incidence of advanced T and N stages at presentation
compared with cervical esophageal squamous cell
carcinoma.

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
15
Q

True or False. Comparing stages, esophageal
squamous cell carcinoma, and adenocarcinoma
have similar survival rates.

A

True

How well did you know this?
1
Not at all
2
3
4
5
Perfectly
16
Q

What imaging modality may play a role in
predicting prognosis in esophageal cancer, and
what is the unit of measurement that is used to
predict prognosis?

A

PET scans. Standardized uptake values (SUV). This has not
borne out in other head and neck cancer thus far, despite
intense evaluation.

17
Q

What overexpression or gene amplification of
what molecular marker has been associated with
poor outcome in esophageal cancer?

A

Human epidermal growth factor receptor (HER-2)

18
Q

What treatment modalities are recommended for

esophageal cancer based on stage?

A

● Stage I: Endoscopic resection vs surgical resection
● Stage II–III: Chemoradiation followed by surgery
● Stage IV: Chemotherapy or best supportive care
Note: Increasing stage is associated with poorer prognosis.

19
Q

What surgical technique is used for primary

cervical esophageal tumors or hypopharyngeal tumors with involvement of the cervical esophagus?

A

Total pharyngo-laryngo-esophagectomy and total pharyngolaryngectomy with cervical esophagectomy

20
Q

What are the reconstructive options after surgery
for cervical esophageal cancer when resection
includes the esophagus below the thoracic inlet?

A

● Gastric transposition (gastric “pull-up”)

● Colonic transposition

21
Q

What are some of the disadvantages of the gastric
transposition (gastric “pull-up”) reconstruction for
pharyngeal and esophageal defects?

A
● High incidence of morbidity and mortality
● Inability to close some defects with oropharyngeal or
nasopharyngeal extension
● Frequent pulmonary complications
● Risk of hypoparathyroidism
● Gastric dumping syndrome
● Gastric outlet obstruction
● Regurgitation
22
Q

What are the reconstructive options after surgery
for cervical esophageal cancer when resection
does not include the esophagus below the
thoracic inlet?

A

● Gastric transposition (gastric “pull-up”)
● Colonic transposition
● Jejunal vascularized free flap
● Tubed fasciocutaneus vascularized free flap

23
Q

What is the major functional disadvantage for patients undergoing jejunal free flap reconstruction for pharyngeal defects?

A

Poor speech and swallowing function. See also dysphagia

and donor-site morbidity. Relatively low rate of stenosis.